Company commits to distinctive actions that will make it easier to navigate the health care system, access care, and achieve better health. HARTFORD, CT (June 23, 2025) — Aetna®, a CVS Health® company ...

GLP-1s are revolutionary drugs in the treatment of obesity, but they're very expensive, and this creates a real barrier to people who need access to these drugs.

Our formulary strategy is centered around providing cost-effective, clinically appropriate prescription coverage We remove barriers to care, increase access to new treatments and make them more ...

DOWNERS GROVE, Ill., May 20, 2025 — Aetna Better Health ® of Illinois, a CVS Health ® company (NYSE: CVS), delivered $20.4 million in value-based care incentive payments to several community health ...

Full Year and Fourth Quarter Highlights: Full year total revenues increased to $268.7 billion, up 4.6% compared to prior year. Full year and fourth quarter GAAP diluted earnings per share from ...

Accelerating momentum through combined strength and innovation of leading businesses. While CVS Health’s business segments continue to be successful and profitable on their own, there is a sizable ...

Roger Farah Named Executive Chairman of the Board. Company provides preliminary guidance for third quarter 2024 GAAP diluted Earnings per Share (EPS) of $0.03 to $0.08 and Adjusted EPS of $1.05 to ...

A single app for consumers’ whole health that provides convenience, savings and ease. WOONSOCKET, R.I., January 28, 2025 — CVS Health® (NYSE: CVS) today announced the launch of the CVS Health app.New ...

Backed by the strength of CVS Health WOONSOCKET, R.I., Oct. 1, 2024 — Aetna®, a CVS Health® company (NYSE: CVS), today announced our 2025 Medicare products bring together what matters most to our ...

The Cordavis products will be FDA approved, high quality and easy for patients to use and will help ensure consistent long-term supply of affordable biosimilars.

WOONSOCKET, R.I., Jan. 3, 2024 — Today CVS Caremark®, a CVS Health® (NYSE: CVS) company, announced the continuation of its efforts to expand adoption of biosimilars.Effective April 1, 2024, Humira® ...

Amy 1 is a working mother with three children in middle school through college. Three years into the pandemic, after cutting back on work, activities and friendships to support her family, she feels ...